tetano
Editor, Senior Moderator
Front Neurol
. 2020 Sep 17;11:1052.
doi: 10.3389/fneur.2020.01052. eCollection 2020.
Neuromuscular Complications With SARS-COV-2 Infection: A Review
Nakul Katyal[SUP] 1 [/SUP], Naureen Narula[SUP] 2 [/SUP], Sudeep Acharya[SUP] 3 [/SUP], Raghav Govindarajan[SUP] 1 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases were first reported in Wuhan, Hubei province of China in December, 2019. SARS- COV-2 primarily affects the cardio-respiratory system. Over the last few months, several studies have described various neurological sequelae of SARS-COV-2 infection. Neurological complications are more frequent in patients with severe respiratory infections. In this review, we have analyzed the current literature on neuromuscular complications associated with SARS-COV-2 and highlighted possible mechanisms of neuromuscular invasion. We reviewed 11 studies describing 11 cases of Guillain Barre syndrome (GBS), and 1 case each of Miller Fisher syndrome, Polyneuritis Cranialis, Acute myelitis, Oculomotor paralysis and Bell's Palsy associated with SARS-COV-2 infection. Mean age of patients with GBS was 61.54 years, with standard deviation (SD) 14.18 years. Majority patients had fever and cough as the first symptom of SARS COV-2 infection. Mean time for onset of neurological symptoms from initial symptoms in 11 patients was 8.18 days, with SD of 2.86 days. Mean time to performing electrodiagnostic study from onset of neurological symptom was 6 days with standard deviation of 3.25. Six patients had demyelinating pattern, three had acute sensory motor axonal neuropathy, and one had acute motor axonal neuropathy on electrodiagnostic studies.
Keywords: COVID 19; SARS-CoV-2; complications; neurology; neuromuscular; pathophysiology
. 2020 Sep 17;11:1052.
doi: 10.3389/fneur.2020.01052. eCollection 2020.
Neuromuscular Complications With SARS-COV-2 Infection: A Review
Nakul Katyal[SUP] 1 [/SUP], Naureen Narula[SUP] 2 [/SUP], Sudeep Acharya[SUP] 3 [/SUP], Raghav Govindarajan[SUP] 1 [/SUP]
Affiliations
- PMID: 33041989
- PMCID: PMC7527465
- DOI: 10.3389/fneur.2020.01052
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases were first reported in Wuhan, Hubei province of China in December, 2019. SARS- COV-2 primarily affects the cardio-respiratory system. Over the last few months, several studies have described various neurological sequelae of SARS-COV-2 infection. Neurological complications are more frequent in patients with severe respiratory infections. In this review, we have analyzed the current literature on neuromuscular complications associated with SARS-COV-2 and highlighted possible mechanisms of neuromuscular invasion. We reviewed 11 studies describing 11 cases of Guillain Barre syndrome (GBS), and 1 case each of Miller Fisher syndrome, Polyneuritis Cranialis, Acute myelitis, Oculomotor paralysis and Bell's Palsy associated with SARS-COV-2 infection. Mean age of patients with GBS was 61.54 years, with standard deviation (SD) 14.18 years. Majority patients had fever and cough as the first symptom of SARS COV-2 infection. Mean time for onset of neurological symptoms from initial symptoms in 11 patients was 8.18 days, with SD of 2.86 days. Mean time to performing electrodiagnostic study from onset of neurological symptom was 6 days with standard deviation of 3.25. Six patients had demyelinating pattern, three had acute sensory motor axonal neuropathy, and one had acute motor axonal neuropathy on electrodiagnostic studies.
Keywords: COVID 19; SARS-CoV-2; complications; neurology; neuromuscular; pathophysiology